Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma
Authors:
- 26 November 2013
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 64 (6) , 847-862
Abstract
Aims: The aim of this study was to examine the status of Brahma (BRM), a key SWI/SNF complex subunit, in clear cell renal cell carcinomas (RCCs), and to analyse the histopathology, immunophenotype, molecular features and prognosis of the BRM‐negative cases.Methods and results: We identified 19 cases of grade 4 tumours lacking BRM expression among 625 clear cell RCCs. All 19 cases exhibited features of poor differentiation: 13 showed pure poorly differentiated morphology, while six were composite tumours with an admixed typical low‐grade component. Besides negative BRM expression, the immunophenotype of these cases was similar to clear cell RCC. VHL gene mutations were identified in nine of the 19 patients (47%). Chromosome 3p deletion was detected in 11 of 13 poorly differentiated RCCs and both areas of five of five composite tumours. All poorly differentiated tumour areas showed polysomy of chromosome 3. No losses or gains of chromosome 3 were observed in low‐grade tumour areas of five of five composite RCCs.Conclusions: We have shown that loss of BRM expression is a common feature among poorly differentiated tumours in clear cell RCCs. We hypothesize that loss of BRM expression is involved in tumor de‐differentiation in clear cell RCCs and may play an important role during tumour progression.Keywords
This publication has 61 references indexed in Scilit:
- Aberrant promoter hypermethylation ofPBRM1,BAP1,SETD2,KDM6Aand other chromatin-modifying genes is absent or rare in clear cell RCCEpigenetics, 2013
- Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivationOncogenesis, 2012
- SMARCB1/INI1 inactivation in renal medullary carcinomaHistopathology, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Sarcomatoid Renal Cell Carcinoma: A Comprehensive Review of the Biology and Current Treatment StrategiesThe Oncologist, 2012
- Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategyOncogene, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasNew England Journal of Medicine, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- The SWI/SNF complex and cancerOncogene, 2009